MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ofid/ofaf021

Медицинская библиотека · Open forum infectious diseases · 2025

Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.

Crawford James M, Penberthy Lynne, Pinto Ligia A, Althoff Keri N, Assimon Magdalene M, Cohen Oren, Gillim Laura, Hammonds Tracy L, Kapur Shilpa, Kaufman Harvey W, Kwasny David, Liew Jean W, Meyer William A, Reynolds Shannon L, Schleicher Cheryl B, Subbiah Suki, Theruviparampil Catherine, Wallace Zachary S, Warner Jeremy L, Yoon Suhyeon, Ziemba Yonah C

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

We developed a United States-based real-world data resource to better understand the continued impact of the coronavirus disease 2019 (COVID-19) pandemic on immunocompromised patients, who are typically underrepresented in prospective studies and clinical trials.

METHODS

The COVID-19 Real World Data infrastructure (CRWDi) was created by linking and harmonizing de-identified HealthVerity medical and pharmacy claims data from 1 December 2018 to 31 December 2023, with severe acute respiratory syndrome coronavirus 2 virologic and serologic laboratory data from major commercial laboratories and Northwell Health; COVID-19 vaccination data; and, for patients with cancer, 2010 to 2021 National Cancer Institute Surveillance, Epidemiology, and End Results registry data.

RESULTS

The CRWDi contains 4 cohorts: patients with cancer; patients with rheumatic diseases receiving pharmacotherapy; noncancer solid organ and hematopoietic stem cell transplant recipients; and people from the general population including adults and pediatric patients. The project successfully linked and harmonized longitudinal, de-identified data on 5.2 million unique patients using privacy-preserving record lineage techniques. The system was developed in early 2024 and rapidly deployed, enabling longitudinal analysis of patient healthcare over the full geography of delivery settings and exploration of novel questions for populations at high risk for adverse outcomes.

CONCLUSIONS

The successful development of the CRWDi enables researchers to address unanswered questions that have arisen during the COVID-19 pandemic. By making the data broadly and freely available to academic researchers, this real-world data system represents an important complement to existing consortia and clinical trials that have emerged during the healthcare crisis and is readily reproducible for future purposing.

Для цитирования: Crawford James M, Penberthy Lynne, Pinto Ligia A, Althoff Keri N, Assimon Magdalene M, Cohen Oren, Gillim Laura, Hammonds Tracy L, Kapur Shilpa, Kaufman Harvey W, Kwasny David, Liew Jean W, Meyer William A, Reynolds Shannon L, Schleicher Cheryl B, Subbiah Suki, Theruviparampil Catherine, Wallace Zachary S, Warner Jeremy L, Yoon Suhyeon, Ziemba Yonah C. Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions.. Open forum infectious diseases. 2025. DOI: 10.1093/ofid/ofaf021.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.